Study of fingolimod, nitric oxide inhibitor, and P-glycoprotein inhibitor in modulating the P-glycoprotein expression via an endothelin-sphingolipid pathway in an animal model of pharmacoresistant epilepsy.
Indian J Pharmacol
; 55(5): 307-314, 2023.
Article
en En
| MEDLINE
| ID: mdl-37929409
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Epilepsia Refractaria
/
Clorhidrato de Fingolimod
Idioma:
En
Revista:
Indian J Pharmacol
Año:
2023
Tipo del documento:
Article